We read with interest the article by Vatankulu et al 1 entitled ''A new parameter predicting chronic total occlusion of coronary arteries: platelet distribution width.'' These authors 1 aimed to assess whether platelet distribution width (PDW) is associated with the extent of coronary artery disease and coronary total occlusions (CTOs).
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In multiple logistic regression analysis, PDW (odds ratio ¼ 1.2, 95% confidence interval [CI] 1.0-1.4; P ¼ .01) was identified as an independent predictor of CTO. In a receiver-operating characteristic analysis, a cut point of 15.7% for PDW was identified in patients with CTO (area under curve ¼ 0.64, 95% CI 0.54-0.75) with a sensitivity of 64% and a specificity of 66%. The authors mentioned that low sensitivity and specificity values of PDW for predicting CTO are due to the positive effect of statins on hematological parameters. They concluded that PDW values can be used as a simple platelet index in predicting the presence of CTO. Some comments may be of interest.
Mean platelet volume (MPV) and PDW are easily measured platelet indices that increase during platelet activation. An increase in both MPV and PDW due to platelet activation is a potentially useful marker for the early diagnosis of thromboembolic diseases. 2, 3 Atorvastatin therapy in patients with hyperlipidemia can significantly decrease the MPV without significant change in PDW. 4 If correlation between statin use and PDW values were given, the effect of statins on PDW values could have been determined more precisely.
In conclusion, platelet indices should not be used alone as direct indicators of thromboembolic disorders. Although PDW may potentially be useful as a predictive marker of cardiovascular diseases, low sensitivity and specificity reduce the value of PDW for predicting CTO.
